This Week at FDA: FDA’s Ad Crackdown, Abandoning AdComms, and MoreSeptember 12, 2025September 15, 2025
This Week at FDA: FDA to Scrutinize Co-Administered Vaccines, New CRLs, and a GLP-1 ‘Green List’September 5, 2025September 15, 2025
Kennedy Tries to Defend COVID-19 Vaccine Stance in Raucous Senate HearingSeptember 4, 2025September 4, 2025
This Week at FDA: CDC Director Fired, FDA Advances New MASH Tool, CMC Pilot ExtendedAugust 29, 2025September 3, 2025
White House Fires CDC Director Who Says RFK Jr. is ‘weaponizing public health’August 28, 2025August 28, 2025
This Week at FDA: Investigation Reveals Extent of HHS RIFs, Makary Updates on CNPV Pilot, FDA to Hold Meeting on User FeesAugust 22, 2025August 26, 2025
FDA Cites Firms for CGMP Violations, Unapproved Products, and Device Reporting IssuesAugust 19, 2025August 26, 2025
